Related Experiment Video
Updated: Jun 16, 2025

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
Annonaceae acetogenins: A potential treatment for gynecological and breast cancer
Diego A Bravo-Alfaro1, Efigenia Montalvo-González2, J Martin Zapien-Macias3
1Tecnologico de Monterrey, Institute of Advanced Materials for Sustainable Manufacturing, Epigmenio González 500 Fracc. San Pablo, Querétaro, Qro 76130, Mexico.
Abstract:
Breast and gynecological cancers are major health concerns due to their increasing incidence rates, and in some cases, their low survival probability. In recent years, multiple compounds of natural origin have been analyzed as alternative treatments for this disease. For instance, Acetogenins are plant secondary metabolites from the Annonaceae family, and its potential anticancer activity has been reported against a wide range of cancer cells both in vitro and in vivo. Several studies have demonstrated promising results of Acetogenins' antitumor capacity, given their selective activity of cellular inhibition at low concentrations. This review outlines the origin, structure, and antineoplastic activities in vitro and in vivo of Acetogenins from Annonaceae against breast cancer and gynecological cancers reported to date. Here, we also provide a systematic summary of the activity and possible mechanisms of action of Acetogenins against these types of cancer and provide references for developing future therapies based on Acetogenins and nanotechnologies.
Insights
Acetogenins from the Annonaceae family show promising anticancer potential against breast and gynecological cancers. This review details their origin, structure, and antitumor activities, suggesting future therapeutic applications.
Area of Science:
- Natural Product Chemistry
- Oncology
- Pharmacology
Background:
- Breast and gynecological cancers pose significant health challenges with increasing incidence and survival concerns.
- Natural compounds are being explored as alternative cancer treatments.
- Acetogenins, plant metabolites from Annonaceae, exhibit documented anticancer activity in vitro and in vivo.
Purpose of the Study:
- To review the origin, structure, and antineoplastic activities of Annonaceae Acetogenins against breast and gynecological cancers.
- To systematically summarize the anticancer mechanisms of Acetogenins.
- To provide references for future Acetogenin-based therapies combined with nanotechnologies.
Main Methods:
- Literature review of studies on Acetogenins from Annonaceae.
- Analysis of in vitro and in vivo antineoplastic activities.
- Systematic summary of reported mechanisms of action.
Main Results:
- Acetogenins demonstrate selective cellular inhibition at low concentrations.
- Promising antitumor capacity reported across various cancer cell lines.
- Evidence supports Acetogenins' potential as anticancer agents.
Conclusions:
- Acetogenins are a promising class of natural compounds for treating breast and gynecological cancers.
- Further research into Acetogenins' mechanisms and combination therapies is warranted.
- Future therapies may integrate Acetogenins with nanotechnologies for enhanced efficacy.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Inhibition of Cdk Activity
Drugs that Stabilize Microtubules
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention
Some...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists